Nuri Bayram - Infectious Diseases

Author Information

Nuri Bayram is affiliated with the University of Health Sciences Dr. Behçet Uz Children's Hospital, specifically within the Department of Pediatric Infectious Diseases in İzmir, Turkey. His work focuses on pediatric infectious diseases, a field in which he has made significant contributions through his research and publications.

Research Contributions

Nuri Bayram has a robust research portfolio primarily centered on infectious diseases affecting children. His recent work includes studies on COVID-19, particularly its impact on children, as well as other infectious agents like H1N1 and methicillin-resistant Staphylococcus aureus (MRSA). He has also explored topics related to pediatric urinary tract infections, Candida-related infections, and tuberculosis diagnostics. His research contributes to understanding pediatric infectious diseases, improving diagnostic challenges, and optimizing treatment strategies in children.

Aliases

Nuri Bayram is known by several aliases in the academic community, including N. Bayram and N Bayram. These variations appear across different publications and academic databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	791
H-index	16
Total Paper Count	133

Publications:

Evaluation of proximal tubule functions at the children with COVID-19 infections: a prospective analytical study

DOI: 10.21203/rs.3.rs-1319027/v1

Year: 2022

Comparison of the pediatric hospitalizations due to COVID‐19 and H1N1pdm09 virus infections during the pandemic period

DOI: 10.1002/jmv.27589

Year: 2022

A Diagnostic Challenge: Is it Tuberculosis?

DOI: 10.1097/INF.0000000000003485

Year: 2022

Changes in the incidence of Candida-related central line-associated bloodstream infections in pediatric intensive care unit: Could central line bundle have a role?

DOI: 10.1016/j.mycmed.2022.101277

Year: 2022

Bacteremia due to healthcare-associated urinary tract infections in children.

DOI: 10.1016/j.arcped.2020.12.003

Year: 2021

Can laboratory findings predict pulmonary involvement in children with COVID‐19 infection?

DOI: 10.1002/ppul.25452

Year: 2021

Answer to commentary to ultrasonographic evaluation of the children with candiduria for the fungal ball: Is it necessary?

DOI: 10.1016/j.jpurol.2021.08.010

Year: 2021

Principles of Appropriate Antimicrobial Therapy and Antibacterial Agents for Pediatric Ear, Nose, and Throat Infections

DOI: 10.1007/978-3-030-80691-0_83

Year: 2021

Upward trend in the frequency of community-acquired methicillin-resistant Staphylococcus aureus as a cause of pediatric skin and soft tissue infections over five years: a cross-sectional study.

DOI: 10.24953/turkjped.2021.02.003

Year: 2021

Evaluation of Children with COVİD-19 in the First Month of the Outbreak in Turkey; Initial Pediatric Data from a Tertiary Hospital

DOI: 10.5222/buchd.2021.80148

Year: 2021

How is HFMD Transmitted?

What is Aedes Albopictus?

What is the Role of the FDA in Infectious Diseases?

What are the Complications of Measles?

What Challenges Does the Global Fund Face?

How is HFMD Diagnosed?

How Does Globalization Affect Infectious Disease Spread?

How Can We Improve Global Health Infrastructure to Combat Infectious Diseases?

What is West Nile Virus?

How Can Pregnant Women Reduce the Risk of Infections?

Partnered Content Networks

Relevant Topics